merck_be_well_green_gray.png
 

Invent. Impact. Inspire.

At Merck, we seek to discover and champion the latest, most promising advancements against the world’s greatest health challenges. To accomplish this, we are willing to invest in solutions that take us in directions we’ve never explored before. Because we’re on a relentless quest for cures. And we’ll be known differently in our industry because of it.

cm_soldier.jpg

 

From Service to Science

Continue your mission of improving lives everywhere.

Pride, respect and a greater sense of purpose are just some of the traits that drew you to the military. As you transition to civilian life, those traits combined with the discipline, teamwork and leadership skills you've earned can continue to impact the lives of people in ways that truly matter – through a career with Merck.


Why Merck?

why_merck.jpg

Whether it’s helping invent the next breakthrough treatment or simply challenging and supporting one another for mutual betterment, our culture is about applied curiosity. We are dedicated to our team members’ growth and development, and empower each of them to reach their full potential regardless of function, geography or experience level.
 

Why Merck? Because we are:

  • committed to fostering development and rewarding talent
  • dedicated to diversity and inclusion at every level of our organization
  • adept at recognizing unique skill sets and nurturing our employees’ talents


DELIVERING ON MERCK’S MISSION

careers_quote_frank_clyburn.png

Our employees meet daunting challenges head on in their quest to contribute to the health and well-being of people around the world. Perhaps there is no greater challenge than conquering cancer and that is what Frank Clyburn set out to do when he began leading Merck’s oncology team in 2013.

 The oncology business was truly a start-up. I started with a team that I could count on one hand. We put a cross-divisional leadership team in place and together we managed to bring one of our most innovative products to market.”
— Frank Clyburn, president, Global Oncology Business Unit